| scholarly article | Q13442814 |
| P2093 | author name string | Li Zhang | |
| Yi Zhang | |||
| Yan Cheng | |||
| Jin-Ming Yang | |||
| Jason Liao | |||
| Shantu Amin | |||
| Arun K Sharma | |||
| Yuan-Wan Sun | |||
| Ugir Hossain Sk | |||
| Kathryn J Huber-Keener | |||
| Xingcong Ren | |||
| P2860 | cites work | Induction of autophagy in temozolomide treated malignant gliomas | Q55463470 |
| Selenium compounds inhibit I kappa B kinase (IKK) and nuclear factor-kappa B (NF-kappa B) in prostate cancer cells | Q64378241 | ||
| Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent | Q73144195 | ||
| Chemopreventive agents: selenium | Q77425293 | ||
| Protection against Fatal Sindbis Virus Encephalitis by Beclin, a Novel Bcl-2-Interacting Protein | Q22003920 | ||
| Interaction of Beclin 1 with survivin regulates sensitivity of human glioma cells to TRAIL-induced apoptosis | Q24338917 | ||
| Partial Beclin 1 silencing aggravates doxorubicin- and Fas-induced apoptosis in HepG2 cells | Q28241857 | ||
| Targeting Akt3 signaling in malignant melanoma using isoselenocyanates | Q33408109 | ||
| Oncogenic ras-induced down-regulation of autophagy mediator Beclin-1 is required for malignant transformation of intestinal epithelial cells | Q33648384 | ||
| Temozolomide and treatment of malignant glioma. | Q33983627 | ||
| Activation of AMP-activated Protein Kinase by Temozolomide Contributes to Apoptosis in Glioblastoma Cells via p53 Activation and mTORC1 Inhibition | Q34412530 | ||
| Synthesis and evaluation of the anti-inflammatory properties of selenium-derivatives of celecoxib. | Q34417632 | ||
| MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents | Q34626127 | ||
| The Akt inhibitor ISC-4 activates prostate apoptosis response protein-4 and reduces colon tumor growth in a nude mouse model. | Q35091427 | ||
| Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4. | Q35535167 | ||
| Selenium in cancer prevention: a review of the evidence and mechanism of action | Q36325137 | ||
| Stress and mTORture signaling | Q36623669 | ||
| Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates. | Q37069862 | ||
| Autophagy: an emerging target for cancer therapy. | Q37117376 | ||
| Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer | Q37707832 | ||
| Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium | Q39972955 | ||
| Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells | Q40600919 | ||
| SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors | Q41487113 | ||
| DNA damage-mediated apoptosis induced by selenium compounds. | Q42801439 | ||
| Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53. | Q43188994 | ||
| Synthesis and antitumor properties of selenocoxib-1 against rat prostate adenocarcinoma cells | Q43240660 | ||
| Se-methylselenocysteine induces apoptosis through caspase activation in HL-60 cells | Q43564035 | ||
| Phase II trial of arsenic trioxide and ascorbic acid with temozolomide in patients with metastatic melanoma with or without central nervous system metastases | Q46704707 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autophagy | Q288322 |
| apoptotic process | Q14599311 | ||
| temozolomide | Q425088 | ||
| P304 | page(s) | e35104 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death | |
| P478 | volume | 7 |
| Q34488011 | Adenovirus-mediated FKHRL1/TM sensitizes melanoma cells to apoptosis induced by temozolomide |
| Q36769227 | Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges |
| Q35148935 | Cytotoxic activity of the methanolic extract of Turnera diffusa Willd on breast cancer cells |
| Q34517339 | Diagnostic and clinical relevance of the autophago-lysosomal network in human gliomas |
| Q27015669 | Friend or foe? The current epidemiologic evidence on selenium and human cancer risk |
| Q38692702 | Glutathione in metastases: From mechanisms to clinical applications |
| Q40231870 | HIF-1α Inhibition Sensitized Pituitary Adenoma Cells to Temozolomide by Regulating Presenilin 1 Expression and Autophagy |
| Q38932012 | Human Lung Cancer Cell Line A-549 ATCC Is Differentially Affected by Supranutritional Organic and Inorganic Selenium. |
| Q37301756 | Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas |
| Q38077547 | Post SELECT: Selenium on Trial |
| Q35658137 | Redox-active selenium compounds--from toxicity and cell death to cancer treatment |
| Q30357185 | Regulation of p53wt glioma cell proliferation by androgen receptor-mediated inhibition of small VCP/p97-interacting protein expression. |
| Q38040788 | Selenium Compounds, Apoptosis and Other Types of Cell Death: An Overview for Cancer Therapy |
| Q38243994 | Selenium action in neuro-oncology |
| Q28087476 | The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System Tumors |
| Q37236107 | Therapeutic Targeting of Autophagy in Disease: Biology and Pharmacology |
| Q57469839 | Tubeimoside-1, a triterpenoid saponin, induces cytoprotective autophagy in human breast cancer cells in vitro via Akt-mediated pathway |
| Q57180130 | Tunable Stability of Imidazotetrazines Leads to a Potent Compound for Glioblastoma |
Search more.